First Responder Successfully Trialled with MSU
Filed with ASX · · 5 pages · English
Summary by 6ix AI
Emvision Medical Devices Ltd. has announced the successful completion of a feasibility study for its First Responder brain scanner, conducted with the Melbourne Mobile Stroke Unit. The study achieved its primary usability and workflow objectives, demonstrating the device's versatility in various real-world environments. Additionally, Emvision signed a Memorandum of Understanding with the Australian Stroke Alliance to pursue funding for pre-hospital stroke diagnosis. The company received a progress payment under the Industry Growth Program to support the development of its First Responder scanner.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
EMvision Medical Devices Ltd. on 6ix
Earlier from EMvision Medical Devices
- Notification regarding unquoted securities - EMV
- emu Regional Benefits Study Advancing
- emu Pivotal Trial Recruitment Surpasses 200 Patients
- Appendix 4E & Annual Report to 30 June 2026
- FY26 Results Presentation
Later from EMvision Medical Devices
- $4.3m Non-Dilutive R&D Tax Rebate Received
- Date of AGM & Closing Date of Director Nominations
- Mayo Clinic emu Early Clinical Experience Presentation
- Notice of Annual General Meeting/Proxy Form
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices